Alzheimer’s vaccine human trial to begin soon

A vaccine to stop Alzheimer's disease which is being spearheaded by an Australian Immunologist is set to begin human trials next week. The study between Professor Nikolai Petrovsky and a US-based medical institute has produced promising results in animal subjects. Testing shows the death of nerve cells and progressive memory loss were delayed by producing antibodies to defend the brain against harmful Abeta proteins. The phase one trial is being conducted in Adelaide and will take roughly a year to conduct.